• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Xanomeline与M(1)和M(2)毒蕈碱型乙酰胆碱受体结合的动力学差异以及G蛋白激活的选择性。

Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors.

作者信息

Jakubík Jan, El-Fakahany Esam E, Dolezal Vladimír

机构信息

Department of Neurochemistry, Institute of Physiology CAS, Vídenská 1083, 14220 Prague, Czech Republic.

出版信息

Mol Pharmacol. 2006 Aug;70(2):656-66. doi: 10.1124/mol.106.023762. Epub 2006 May 4.

DOI:10.1124/mol.106.023762
PMID:16675658
Abstract

Xanomeline is a functionally selective M(1)/M(4) muscarinic acetylcholine receptor agonist that nevertheless binds with high affinity to all five subtypes of muscarinic receptors. A novel mode of interaction of this ligand with the muscarinic M(1) receptors characterized by persistent binding and receptor activation after extensive washout has been shown previously. In the present study, using human M(1) and M(2) receptors expressed in Chinese hamster ovary cells and [(3)H]N-methylscopolamine as a tracer, we show that persistent binding of xanomeline also occurs at the M(2) receptor with similar affinity as at the M(1) receptor (K(I) = 294 and 296 nM, respectively). However, kinetics of formation of xanomeline wash-resistant binding to M(2) receptors was markedly slower than to M(1) receptors. Xanomeline was a potent fast-acting full agonist in stimulating guanosine 5'-O-(3-[(35)S]thio)triphosphate binding at M(1) receptors, whereas at M(2) receptors it behaved as a potent partial agonist (40% of carbachol maximal response) only upon preincubation for 1 h. Development of xanomeline agonistic effects at the M(2) receptor was slower than its ability to attenuate carbachol responses. We also demonstrate that xanomeline discriminates better between G protein subtypes at M(1) than at M(2) receptors. Our data support the notion that xanomeline interacts with multiple sites on the muscarinic receptor, resulting in divergent conformations that exhibit differential effects on ligand binding and receptor activation. These conformations are both time- and concentration-dependent and vary between the M(1) and the M(2) receptor.

摘要

占诺美林是一种功能选择性M(1)/M(4)毒蕈碱型乙酰胆碱受体激动剂,不过它能以高亲和力与毒蕈碱受体的所有五种亚型结合。此前已表明,该配体与毒蕈碱M(1)受体存在一种新型相互作用模式,其特征为在大量冲洗后仍能持续结合并激活受体。在本研究中,我们利用在中国仓鼠卵巢细胞中表达的人M(1)和M(2)受体以及[(3)H]N-甲基东莨菪碱作为示踪剂,发现占诺美林在M(2)受体上也会发生持续结合,其亲和力与在M(1)受体上相似(解离常数分别为294和296 nM)。然而,占诺美林与M(2)受体形成耐冲洗结合的动力学明显慢于与M(1)受体的结合。占诺美林是一种强效速效的完全激动剂,可刺激M(1)受体上的鸟苷5'-O-(3-[(35)S]硫代)三磷酸结合,而在M(2)受体上,只有在预孵育1小时后,它才表现为强效部分激动剂(为卡巴胆碱最大反应的40%)。占诺美林在M(2)受体上激动效应的产生比其减弱卡巴胆碱反应的能力更慢。我们还证明,占诺美林在M(1)受体上对G蛋白亚型的区分能力优于在M(2)受体上。我们的数据支持这样一种观点,即占诺美林与毒蕈碱受体上的多个位点相互作用,导致不同的构象,这些构象对配体结合和受体激活表现出不同的影响。这些构象既依赖时间也依赖浓度,并且在M(1)和M(2)受体之间有所不同。

相似文献

1
Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors.Xanomeline与M(1)和M(2)毒蕈碱型乙酰胆碱受体结合的动力学差异以及G蛋白激活的选择性。
Mol Pharmacol. 2006 Aug;70(2):656-66. doi: 10.1124/mol.106.023762. Epub 2006 May 4.
2
Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor.占诺美林对毒蕈碱M5受体的持续结合与功能拮抗作用。
J Pharmacol Exp Ther. 2005 Oct;315(1):313-9. doi: 10.1124/jpet.105.090134. Epub 2005 Jul 7.
3
Wash-resistantly bound xanomeline inhibits acetylcholine release by persistent activation of presynaptic M(2) and M(4) muscarinic receptors in rat brain.耐洗结合的占诺美林通过持续激活大鼠脑中突触前M(2)和M(4)毒蕈碱受体来抑制乙酰胆碱释放。
J Pharmacol Exp Ther. 2007 Jul;322(1):316-23. doi: 10.1124/jpet.107.122093. Epub 2007 Apr 19.
4
Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor.占诺美林持续结合对竞争性配体与M1毒蕈碱型乙酰胆碱受体相互作用的变构调节。
J Pharmacol Exp Ther. 2002 Jun;301(3):1033-41. doi: 10.1124/jpet.301.3.1033.
5
Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex.由洗不脱的占诺美林-受体复合物瞬间形成所诱导的毒蕈碱M1受体的长期变化。
J Pharmacol Exp Ther. 2007 Dec;323(3):868-76. doi: 10.1124/jpet.107.129940. Epub 2007 Sep 12.
6
Long-term activation upon brief exposure to xanomleline is unique to M1 and M4 subtypes of muscarinic acetylcholine receptors.短暂接触占诺美林后长期激活是M1和M4毒蕈碱型乙酰胆碱受体亚型所特有的。
PLoS One. 2014 Feb 18;9(2):e88910. doi: 10.1371/journal.pone.0088910. eCollection 2014.
7
Long-term wash-resistant effects of brief interaction of xanomeline at the M1 muscarinic receptor.占诺美林与M1毒蕈碱受体短暂相互作用的长期抗洗脱效应。
Neurosci Lett. 2006 Dec 13;410(1):11-4. doi: 10.1016/j.neulet.2006.09.062. Epub 2006 Oct 18.
8
Pharmacological analysis of the novel mode of interaction between xanomeline and the M1 muscarinic acetylcholine receptor.新型药物占诺美林与M1毒蕈碱型乙酰胆碱受体相互作用模式的药理学分析
J Pharmacol Exp Ther. 1999 Jun;289(3):1220-8.
9
On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.关于占诺美林在M1毒蕈碱型乙酰胆碱受体上的独特结合和激活特性
Mol Pharmacol. 1998 Jun;53(6):1120-30.
10
Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors.毒蕈碱受体激动剂占诺美林对5-羟色胺1型和5-羟色胺2型受体的功能作用。
Br J Pharmacol. 1998 Dec;125(7):1413-20. doi: 10.1038/sj.bjp.0702201.

引用本文的文献

1
Current Findings and Potential Mechanisms of KarXT (Xanomeline-Trospium) in Schizophrenia Treatment.当前 KarXT(盐酸二甲苯噻嗪-托吡酯)治疗精神分裂症的研究结果及潜在机制。
Clin Drug Investig. 2024 Jul;44(7):471-493. doi: 10.1007/s40261-024-01377-9. Epub 2024 Jun 21.
2
Agonist-selective activation of individual G-proteins by muscarinic receptors.毒蕈碱型乙酰胆碱受体对单个 G 蛋白的激动剂选择性激活。
Sci Rep. 2024 Apr 26;14(1):9652. doi: 10.1038/s41598-024-60259-4.
3
Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia.占诺美林-曲司氯铵与精神分裂症中的毒蕈碱参与
Neuropsychiatr Dis Treat. 2023 May 10;19:1145-1151. doi: 10.2147/NDT.S406371. eCollection 2023.
4
Structural basis of efficacy-driven ligand selectivity at GPCRs.激动型 G 蛋白偶联受体配体选择性的结构基础
Nat Chem Biol. 2023 Jul;19(7):805-814. doi: 10.1038/s41589-022-01247-5. Epub 2023 Feb 13.
5
Vibrational spectroscopy analysis of ligand efficacy in human M muscarinic acetylcholine receptor (MR).配体在人 M 毒蕈碱型乙酰胆碱受体(MR)中效能的振动光谱分析。
Commun Biol. 2021 Nov 23;4(1):1321. doi: 10.1038/s42003-021-02836-1.
6
Fusion with Promiscuous Gα Subunit Reveals Signaling Bias at Muscarinic Receptors.与混杂 Gα 亚基融合揭示毒蕈碱受体的信号转导偏向性。
Int J Mol Sci. 2021 Sep 18;22(18):10089. doi: 10.3390/ijms221810089.
7
Restoring Agonist Function at a Chemogenetically Modified M Muscarinic Acetylcholine Receptor.恢复化学遗传修饰的 M 型毒蕈碱乙酰胆碱受体的激动剂功能。
ACS Chem Neurosci. 2020 Dec 16;11(24):4270-4279. doi: 10.1021/acschemneuro.0c00540. Epub 2020 Nov 16.
8
Current Advances in Allosteric Modulation of Muscarinic Receptors.当前乙酰胆堿能受体变构调节的研究进展。
Biomolecules. 2020 Feb 18;10(2):325. doi: 10.3390/biom10020325.
9
Novel M -selective, G -biased agonists of muscarinic acetylcholine receptors.新型 M 型选择性、G 蛋白偏向性毒蕈碱型乙酰胆碱受体激动剂。
Br J Pharmacol. 2020 May;177(9):2073-2089. doi: 10.1111/bph.14970. Epub 2020 Feb 15.
10
Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer's Disease.设计针对胆碱能系统的杂种分子:通过调节毒蕈碱和烟碱受体来治疗阿尔茨海默病的一种概念。
Molecules. 2018 Dec 7;23(12):3230. doi: 10.3390/molecules23123230.